This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced an ...

Explore how AI transforms cancer drug discovery by predicting proteins and accelerating drug candidate identification and ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitementand skepticism ...

Partnership Will Harness NYSCF's Automated Cell Culture Systems and Artificial Intelligence Capabilities to Study Disease at ...

By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...

Seasoned advisory group including RNA, translation and commercialisation luminaries.

At both Biotech Showcase and RESI JPM, BullFrog AI will highlight its proprietary BullFrog Data Networks ®, a data insights tool powered by the bfLEAP™ platform. BullFrog Data Networks ® evaluate high ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

Pfizer is expanding its collaboration with the start-up PostEra, which applies artificial intelligence to medicinal chemistry ...